Unprecedented success of rituximab therapy for prednisolone- and immunosuppressant-resistant systemic sclerosis-associated interstitial lung disease

被引：10
|
作者：
Ebata, S. [1 ]
Yoshizaki, A. [1 ]
Fukasawa, T. [1 ]
Nakamura, K. [1 ]
Yamashita, T. [1 ]
Miura, S. [1 ]
Saigusa, R. [1 ]
Ichimura, Y. [1 ]
Takahashi, T. [1 ]
Hirabayashi, M. [1 ]
Taniguchi, T. [1 ]
Akamata, K. [1 ]
Asano, Y. [1 ]
Sato, S. [1 ]
机构：
[1] Univ Tokyo, Dept Dermatol, Fac Med, Tokyo, Japan
来源：
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 2017年 / 46卷 / 03期
关键词：
D O I：
10.1080/03009742.2016.1231341
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：247 / 249
页数：3
相关论文
共 50 条
  • [41] Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
    Meier, C.
    Freiburghaus, K.
    Bovet, C.
    Schniering, J.
    Allanore, Y.
    Distler, O.
    Nakas, C.
    Maurer, B.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [42] The hidden costs of living with systemic sclerosis-associated interstitial lung disease
    Parfrey, Helen
    RESPIROLOGY, 2022, 27 (07) : 486 - 487
  • [43] Severity and features of frailty in systemic sclerosis-associated interstitial lung disease
    Guler, Sabina A.
    Kwan, Joanne M.
    Winstone, Tiffany A.
    Milne, Kathryn M.
    Dunne, James V.
    Wilcox, Pearce G.
    Ryerson, Christopher J.
    RESPIRATORY MEDICINE, 2017, 129 : 1 - 7
  • [44] RITUXIMAB AS RESCUE THERAPY IN ADVANCED PROGRESSIVE SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE
    Kokosi, M.
    Saunders, P.
    Karagiannis, K.
    Chua, F.
    Maher, T. M.
    Renzoni, E. A.
    Wells, A. U.
    THORAX, 2015, 70 : A92 - A92
  • [45] Management of systemic sclerosis-associated interstitial lung disease in the current era
    Amjadi, Sogol Sara
    Roofeh, David
    Namas, Rajaie
    Khanna, Dinesh
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (02) : 137 - 139
  • [46] Treatment of systemic sclerosis-associated interstitial lung disease: a work in progress
    Oldham, Justin M.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (01): : 5 - 7
  • [47] Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
    Bautista-Sanchez, Rocio
    Khanna, Dinesh
    RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2024, 5 (03): : 157 - 165
  • [48] Recent advances in the management of systemic sclerosis-associated interstitial lung disease
    Hoffmann-Vold, Anna-Maria
    Distler, Oliver
    Crestani, Bruno
    Antoniou, Katerina M.
    CURRENT OPINION IN PULMONARY MEDICINE, 2022, 28 (05) : 441 - 447
  • [49] Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature
    Bonhomme, Olivier
    Andre, Beatrice
    Gester, Fanny
    de Seny, Dominique
    Moermans, Catherine
    Struman, Ingrid
    Louis, Renaud
    Malaise, Michel
    Guiot, Julien
    RHEUMATOLOGY, 2019, 58 (09) : 1534 - 1546
  • [50] Patient and Physician Perspectives on Systemic Sclerosis-Associated Interstitial Lung Disease
    Cheema, Tariq J.
    Young, Meilin
    Rabold, Erica
    Barbieri, Ashley N.
    Baldwin, Nancy
    Steen, Virginia D.
    CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2020, 14
12345